These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1846710)

  • 1. Accelerated cardiac allograft rejection in murine cytomegalovirus-infected C3H recipients.
    Shao YL; Shelby J; Hisatake G; Kern ER; Nelson EW; Gay WA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):129-30. PubMed ID: 1846710
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated rejection of murine cardiac allografts by murine cytomegalovirus-infected recipients. Lack of haplotype specificity.
    Carlquist JF; Shelby J; Shao YL; Greenwood JH; Hammond ME; Anderson JL
    J Clin Invest; 1993 Jun; 91(6):2602-8. PubMed ID: 8390486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor. A new application for cytomegalovirus-induced neutropenia in cardiac allograft recipients.
    Patel HD; Anderson JR; Duncombe AS; Carrington D; Murday A
    Transplantation; 1994 Oct; 58(7):863-7. PubMed ID: 7940727
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
    O'Hair DP; Johnson CP; Roza AM; Adams MB
    Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537
    [No Abstract]   [Full Text] [Related]  

  • 6. CMV infection and allograft rejection.
    Häyry P; Lemström K; von Willebrand E; Tikkanen J; Koskinen P
    Transplant Proc; 1998 May; 30(3):916-7. PubMed ID: 9595145
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
    Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus-associated allograft rejection in heart transplant patients.
    Potena L; Valantine HA
    Curr Opin Infect Dis; 2007 Aug; 20(4):425-31. PubMed ID: 17609604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
    Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
    Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients.
    Rancewicz Z; Halama G; Smogorzewski M; Durlik M; Rowinska D; Lao M; Juskowa J; Wyzgal J
    Transplant Proc; 1990 Aug; 22(4):1818-9. PubMed ID: 2167538
    [No Abstract]   [Full Text] [Related]  

  • 13. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated rejection of Fas ligand-expressing heart grafts.
    Takeuchi T; Ueki T; Nishimatsu H; Kajiwara T; Ishida T; Jishage K; Ueda O; Suzuki H; Li B; Moriyama N; Kitamura T
    J Immunol; 1999 Jan; 162(1):518-22. PubMed ID: 9886428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy.
    Mangiavacchi M; Frigerio M; Gronda E; Danzi GB; Bonacina E; Masciocco G; Olivia F; De Vita C; Pellegrini A
    Transplant Proc; 1995 Jun; 27(3):1960-2. PubMed ID: 7792851
    [No Abstract]   [Full Text] [Related]  

  • 16. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis.
    Li F; Grauls G; Yin M; Bruggeman CA
    Transplant Proc; 1995 Dec; 27(6):3552-4. PubMed ID: 8540098
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.